
Please try another search
Cronex.Co.,Ltd engages in the research and development of medicines and raw materials for medical research. The company offers contract research organization services for dental materials, various implant materials, bone marrow restorations, and bone regeneration, skin penetration, high-frequency therapy device, patch drug test, biological dressing material, wound dressing, franz diffusion test skin; spinal implant efficacy evaluation, bone defect bone graft material efficacy evaluation, cartilage regeneration efficacy evaluation, X-ray, micro-CT, and histology; drug effectiveness evaluation experiments for new drug development using minipigs, beagle dogs, and rabbits; preclinical efficacy evaluation using medium-sized animals; and test progress, animal management, animal anesthesia, post-test management of animals, sampling, and test evaluation services. It also provides medical collagens and disease testing services; and engages in research on a transgenic pig model using gene editing technology and somatic cell nuclear transfer technology to overexpress foreign genes or remove existing genes. The company was incorporated in 2012 and is based in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Young-Gil Lee | 60 | - | VP & Director |
Young-Joon Son | 49 | - | CEO & Director |
Hyeok Kim | - | 2022 | Director |
CheonGyu Park | - | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review